Cargando…

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients

BACKGROUND: Circulating tumor cells (CTCs) are prognostic biomarker in non-small-cell lung cancer (NSCLC). CTCs could also be used as predictor of efficacy of systemic treatments in advanced NSCLC. OBJECTIVES: We described the dynamic changes of CTCs during first-line platinum-based chemotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhen, Zhang, Xu-Chao, Feng, Wei-Neng, Zhang, Li, Liu, Xiao-Qing, Guo, Wei-Bang, Deng, Yan-Ming, Zou, Qing-Feng, Yang, Jin-Ji, Zhou, Qing, Wang, Bin-Chao, Chen, Hua-Jun, Tu, Hai-Yan, Yan, Hong-Hong, Wu, Yi-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126699/ https://www.ncbi.nlm.nih.gov/pubmed/37113733 http://dx.doi.org/10.1177/17588359231167818

Ejemplares similares

Clinical outcomes of EGFR +/ METamp+ vs. EGFR +/ METamp‐ untreated patients with advanced non‐small cell lung cancer
por: Peng, Kai‐Cheng, et al.
Publicado: (2022)

Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer
por: Wu, Zhuo-Xuan, et al.
Publicado: (2016)

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression
por: Chen, Rui-Lian, et al.
Publicado: (2018)

Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020)

Correlation between circulating endothelial cell level and acute respiratory distress syndrome in postoperative patients
por: Peng, Min, et al.
Publicado: (2021)

Survival Mechanisms and Influence Factors of Circulating Tumor Cells
por: Wang, Wen-Chao, et al.
Publicado: (2018)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
por: Yin, Liang-Chun, et al.
Publicado: (2018)

Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer
por: Gao, Hong-Fei, et al.
Publicado: (2016)

Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer
por: Zhang, Zhen-yu, et al.
Publicado: (2014)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations
por: Lou, Na-Na, et al.
Publicado: (2016)

Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells
por: Ren, WeiHong, et al.
Publicado: (2020)

The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation
por: Wang, Ying, et al.
Publicado: (2014)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy
por: Tong, Bing, et al.
Publicado: (2017)

Long-Term Survival and Prognostic Factors in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with TPF Induction Chemotherapy followed by Cisplatin-Combined Concurrent Chemoradiotherapy
por: Zhang, Qun, et al.
Publicado: (2019)

Impact of thoracic radiation therapy after chemotherapy on survival in extensive‐stage small cell lung cancer: A propensity score‐matched analysis
por: Deng, Lei, et al.
Publicado: (2019)

Gastrointestinal-type chemotherapy prolongs survival in an atypical primary ovarian mucinous carcinoma: A case report
por: Wang, Qi, et al.
Publicado: (2021)

Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer
por: Kang, Jin, et al.
Publicado: (2018)

The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor
por: Wang, Qi, et al.
Publicado: (2019)

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
por: Wang, Hai-ying, et al.
Publicado: (2020)

Detection of circulating Mycobacterium tuberculosis-specific DNA by droplet digital PCR for vaccine evaluation in challenged monkeys and TB diagnosis
por: Song, Neng, et al.
Publicado: (2018)

Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma
por: Yu, Ying, et al.
Publicado: (2020)

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy
por: Dong, Song, et al.
Publicado: (2010)

Prognostic value of circulating tumor cells in esophageal cancer
por: Xu, Hai-Tao, et al.
Publicado: (2017)

Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Cai, Gengxi, et al.
Publicado: (2022)

Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
por: Gao, Xin, et al.
Publicado: (2020)

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
por: Zhang, Jian-Wei, et al.
Publicado: (2014)

Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy
por: Li, Liang-Liang, et al.
Publicado: (2017)

Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial
por: Wang, De-Shen, et al.
Publicado: (2021)

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis
por: Xiao, WeiWei, et al.
Publicado: (2022)

Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis
por: Yan, Wen-Ting, et al.
Publicado: (2017)

miR129-1 regulates protein phosphatase 1D protein expression under hypoxic conditions in non-small cell lung cancer cells harboring a TP53 mutation
por: Yin, Hong-Lei, et al.
Publicado: (2020)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
por: Kang, Jin, et al.
Publicado: (2020)

Surgical Treatment of Osteosarcoma Induced Distant Pre‐Metastatic Niche in Lung to Facilitate the Colonization of Circulating Tumor Cells
por: Tang, Fan, et al.
Publicado: (2023)

Decreased numbers and sex-based differences of circulating regulatory T cells in patients with seropositive undifferentiated arthritis
por: Niu, Hong-Qing, et al.
Publicado: (2021)

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial
por: Zhong, Wen-Zhao, et al.
Publicado: (2023)

A nomogram model integrating LI-RADS features and radiomics based on contrast-enhanced magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma falling the Milan criteria
por: Liu, Hai-Feng, et al.
Publicado: (2022)

The clinical value of circulating tumor DNA detection in advanced non-small cell lung cancer
por: Lin, Xiao, et al.
Publicado: (2019)

Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
por: He, Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ad9q1bimu1658ojohbpmm60bl1